ioo;;-~~ ." - ,
Immunological validation of α2MB, Apo E and Apo A1 as potential diagnostic biomarkers.
Dr. Michael A. Davies, MD | Houston, TX | Oncologist | US News Doctors
Untitled
Investigating Serum and Tissue Expression Identified a Cytokine/Chemokine Signature as a Highly Effective Melanoma Marker
Premio Roma - Albo d'oro 2019
Giancarlo Cappellini - CONSULENTE INFORMATICO - PRISMA SOFTWARE SRL | LinkedIn
gian carlo antonini cappellini - Oncologist - Ospedale Sandro Pertini - ASL RM2 | LinkedIn
7 perfiles de «Carlo Cappellini» | LinkedIn
Giancarlo Antonini (@gcarloantonini) / Twitter
Gian CAPPELLINI | Istituto Dermopatico dell'Immacolata, Rome | IDI | Oncologia
Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma | Journal of Translational Medicine | Full Text
Giancarlo CAPPELLINI | Istituto Dermopatico dell'Immacolata, Rome | IDI
Differential Denaturation of Serum Proteome Reveals a Significant Amount of Hidden Information in Complex Mixtures of Proteins | PLOS ONE
Circulating miR-1246 and miR-485-3p as Promising Biomarkers of Clinical Response and Outcome in Melanoma Patients Treated with T
Investigating Serum and Tissue Expression Identified a Cytokine/Chemokine Signature as a Highly Effective Melanoma Marker
Gian CAPPELLINI | Istituto Dermopatico dell'Immacolata, Rome | IDI | Oncologia
Genomic Classification of Cutaneous Melanoma - ScienceDirect
Genomic Classification of Cutaneous Melanoma - University of Miami
TRIDENT analysis of melanoma vs control sera.
Frontiers | Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future Perspectives
Giancarlo Antonini (@gcarloantonini) / Twitter
